Author(s):
Juni Handajani, Endang Winiati Bachtiar, Irene Edith Rieuwpassa, Widya Lestari
Email(s):
junihandajani@ugm.ac.id
DOI:
10.52711/0974-360X.2026.00616 
Address:
Juni Handajani1*, Endang Winiati Bachtiar2, Irene Edith Rieuwpassa3, Widya Lestari4
1Department of Oral Biology, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia.
2Department of Oral Biology, Faculty of Dentistry, University Indonesia, Jakarta, Indonesia.
3Department of Oral Biology, Faculty of Dentistry, Universitas Hasanuddin, Makassar, Indonesia.
4Fundamental Dental and Medical Sciences, Kulliyyah of Dentistry, International Islamic University Malaysia, Jalan Sultan Ahmad Shah, Kuantan, Malaysia.
*Corresponding Author
Published In:
Volume - 19,
Issue - 9,
Year - 2026
ABSTRACT:
Advances in immune engineering aim to accelerate tissue regeneration. Macrophages play a crucial role in regulating the initiation of regeneration, balancing it through pro-inflammatory (M1) and reparative (M2) activities. Exosomes from dental pulp stem cells (DPSCs) carry osteogenic signals that can promote bone formation and accelerate hard tissue recovery. DPSC-derived exosomes with macrophage secretome synergistically modulate immunity and enhance osteogenesis through the secretion of TGF-ß, BMP-2, and IGF-1, thus representing a potential strategy for repairing large bone defects. The aim of this study was to measure the growth factor concentration of exosomes from DSPCs and macrophage secretome and their effects on osteoblast viability. This study measured osteogenic growth factors in DPSC and mononuclear cell (MNC) exosomes and in macrophage secretome isolated with ExoQuick, quantified TGF-ß, BMP-2, and IGF-1 by ELISA (read at 450 nm), and assessed effects on MG63 osteoblast viability using the MTT assay. Statistical analysis used ANOVA with Games-Howell post hoc. Results showed macrophage secretome supplemented with FBS contained significantly higher TGF-ß, BMP-2, and IGF-1 than DPSC or MNC exosomes, and produced the greatest osteoblast viability (>90%). Adding FBS increased measured growth factor levels. We concluded that macrophage secretome and DPSCs were primary sources of these growth factors and that FBS supplementation enhances their osteogenic potential to promote bone regeneration.
Cite this article:
Juni Handajani, Endang Winiati Bachtiar, Irene Edith Rieuwpassa, Widya Lestari. Exosomal Growth Factors from Dental Pulp Stem Cells (DSPCs) and Macrophage Secretome: Impact on Osteoblast Viability. Research Journal Pharmacy and Technology. 2026;19(9):4416-2. doi: 10.52711/0974-360X.2026.00616
Cite(Electronic):
Juni Handajani, Endang Winiati Bachtiar, Irene Edith Rieuwpassa, Widya Lestari. Exosomal Growth Factors from Dental Pulp Stem Cells (DSPCs) and Macrophage Secretome: Impact on Osteoblast Viability. Research Journal Pharmacy and Technology. 2026;19(9):4416-2. doi: 10.52711/0974-360X.2026.00616 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-9-62
REFERENCES:
1. Wculek SK, Dunphy G, Heras-Murillo I, Mastrangelo A, Sancho D. Metabolism of tissue macrophages in homeostasis and pathology. Cell Mol Immunol. 2022 Mar; 19(3): 384-408. doi: 10.1038/s41423-021-00791-9. Epub 2021 Dec 7. PMID: 34876704; PMCID: PMC8891297.
2. Gou M, Wang H, Xie H, Song H. Macrophages in guided bone regeneration: potential roles and future directions. Front Immunol. 2024 Apr 26; 15: 1396759. doi: 10.3389/fimmu.2024.1396759. PMID: 38736888; PMCID: PMC11082316.
3. Mu M, Gao P, Yang Q, He J, Wu F, Han X, Guo S, Qian Z, Song C. Alveolar Epithelial Cells Promote IGF-1 Production by Alveolar Macrophages Through TGF-β to Suppress Endogenous Inflammatory Signals. Front Immunol. 2020 Jul 21; 11: 1585. doi: 10.3389/fimmu.2020.01585. PMID: 32793225; PMCID: PMC7385185.
4. Mu M, GaoP, Yang Q, He J, Wu F, Han X, Guo S, Qian Z and Song C (2020) Alveolar Epithelial Cells Promote IGF-1 Production by Alveolar Macrophages Through TGF-β to Suppress Endogenous Inflammatory Signals. Front. Immunol. 11: 1585. doi: 10.3389/fimmu.2020.01585
5. Murayama M, Chow SK, Lee ML, Young B, Ergul YS, Shinohara I, Susuki Y, Toya M, Gao Q, Goodman SB. The interactions of macrophages, lymphocytes, and mesenchymal stem cells during bone regeneration. Bone Joint Res. 2024 Sep 6; 13(9): 462-473. doi: 10.1302/2046-3758.139.BJR-2024-0122.R1. PMID: 39237112; PMCID: PMC11377107.
6. Lu Y, Mai Z, Cui L, Zhao X. Engineering exosomes and biomaterial-assisted exosomes as therapeutic carriers for bone regeneration. Stem Cell Res Ther. 2023 Mar 29; 14(1): 55. doi: 10.1186/s13287-023-03275-x. PMID: 36978165; PMCID: PMC10053084.
7. Lu GD, Cheng P, Liu T, Wang Z. BMSC-Derived Exosomal miR-29a Promotes Angiogenesis and Osteogenesis. Front Cell Dev Biol. 2020 Dec 9; 8: 608521. doi: 10.3389/fcell.2020.608521. PMID: 33363169; PMCID: PMC7755650.
8. Zou ML, Chen ZH, Teng YY, Liu SY, Jia Y, Zhang KW, Sun ZL, Wu JJ, Yuan ZD, Feng Y, Li X, Xu RS, Yuan FL. The Smad Dependent TGF-β and BMP Signaling Pathway in Bone Remodeling and Therapies. Front Mol Biosci. 2021 May 5;8:593310. doi: 10.3389/fmolb.2021.593310. PMID: 34026818; PMCID: PMC8131681.
9. Luo X, Meng C, Zhang Y, Du Q, Hou C, Qiang H, Liu K, Lv Z, Li J, Liu F. MicroRNA-21a-5p-modified macrophage exosomes as natural nanocarriers promote bone regeneration by targeting GATA2. Regen Biomater. 2023 Aug 31; 10: rbad075. doi: 10.1093/rb/rbad075. PMID: 37719929; PMCID: PMC10504470.
10. Arun M, Rajasingh S, Madasamy P, Rajasingh J. Immunomodulatory and Regenerative Functions of MSC-Derived Exosomes in Bone Repair. Bioengineering (Basel). 2025 Aug 5;12(8):844. doi: 10.3390/bioengineering12080844. PMID: 40868357; PMCID: PMC12383523.
11. Ren Y, Zhao W, Liu M, Lin H. Macrophage Polarization in Heterotopic Ossification: Inflammation, Osteogenesis, and Emerging Therapeutic Targets. Int J Mol Sci. 2025 Jun 17; 26(12): 5821. doi: 10.3390/ijms26125821. PMID: 40565283; PMCID: PMC12192979.
12. Yuan VG. Polarized Macrophages and Their Exosomes: Implications for Autoimmune and Immune-Mediated Diseases. Biology. 2025; 14(10): 1371. https://doi.org/10.3390/biology14101371
13. Gharavi AT, Asadi Hanjani N, Movahed E, Doroudian M. The role of macrophage subtypes and exosomes in immunomodulation. Cell Mol Biol Lett. 2022;27:83. doi:10.1186/s11658-022-00384-y
14. Wang L, Ruan M, Bu Q, Zhao C. Signaling Pathways Driving MSC Osteogenesis: Mechanisms, Regulation, and Translational Applications. Int J Mol Sci. 2025 Feb 4; 26(3): 1311. doi: 10.3390/ijms26031311. PMID: 39941080; PMCID: PMC11818554.
15. Vig S, Fernandes MH. Bone Cell Exosomes and Emerging Strategies in Bone Engineering. Biomedicines. 2022 Mar 24; 10(4): 767. doi: 10.3390/biomedicines10040767. PMID: 35453517; PMCID: PMC9033129.
16. Bachtiar EW, Ali S, Vitria EE, Sugianto TD. Secretome analysis of dental pulp stem cell (DPSC) for hard tissue regeneration. AIP Conf Proc. 2024; 2710:040003. doi:10.1063/5.0144052
17. Fu XH, Li JP, Li XY, Tan Y, Zhao M, Zhang SF, Wu XD, Xu JG. M2 Macrophage Derived Exosomes Promote Meningioma Progression through TGF β Signaling Pathway. J Immunol Res. 2022; 2022: 8326591. doi:10.1155/2022/8326591.
18. Manda Handzlik A, Cieloch A, Kuźmicka W, Mroczek A, Stelmaszczyk Emmel A, Demkow U, Wachowska M. Secretomes of M1 and M2 macrophages decrease the release of neutrophil extracellular traps. Scientific Reports. 2023; 13: 15633. doi:10.1038/s41598-023-42167-1. PMID:37730741. PMCID:PMC10511515.
19. Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002 Aug; 2(8): 569-79. doi: 10.1038/nri855. PMID: 12154376.
20. Budi HS, Handajani J, Amir LR, Soekanto SA, Ulfa NM, Wulansari SA, Shen YK, Yamada S. Nanoemulgel Development of Stem Cells from Human Exfoliated Deciduous Teeth-Derived Conditioned Medium as a Novel Nanocarrier Growth Factors. Eur J Dent. 2025 Apr 23. doi: 10.1055/s-0045-1806963. Epub ahead of print. PMID: 40267955.
21. Liu S, Yang W, Li Y, Sun C. Fetal bovine serum, an important factor affecting the reproducibility of cell experiments. Sci Rep. 2023;13:1942. doi:10.1038/s41598-023-29060-7.
22. Sugawara K, Kizaki K, Herath CB, Hasegawa Y, Hashizume K. Transforming growth factor beta family expression at the bovine feto-maternal interface. Reprod Biol Endocrinol. 2010 Oct 15;8:120. doi: 10.1186/1477-7827-8-120. PMID: 20950427; PMCID: PMC2970602.
23. Vi L, Baht GS, Whetstone H, Huang J, Gardiner EM, Jiang S, et al. Macrophages promote osteogenesis and support bone healing through paracrine signaling. J Bone Miner Res. 2015;30(7):1234–1245.
24. Snarski P, Sukhanov S, Yoshida T, Higashi Y, Danchuk S, Chandrasekar B, Tian D, Rivera-Lopez V, Delafontaine P. Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice. Arterioscler Thromb Vasc Biol. 2022 Feb;42(2):113-126. doi: 10.1161/ATVBAHA.121.316090. Epub 2021 Dec 2. PMID: 34852642; PMCID: PMC8792341.
25. Wynn TA, Vannella KM. Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity. 2016 Mar 15;44(3):450-462. doi: 10.1016/j.immuni.2016.02.015. PMID: 26982353; PMCID: PMC4794754.
26. Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Théry C. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77. doi: 10.1073/pnas.1521230113. Epub 2016 Feb 8. PMID: 26858453; PMCID: PMC4776515.
27. Niada S, Giannasi C, Magagnotti C, Andolfo A, Brini AT. Proteomic analysis of extracellular vesicles and conditioned medium from human adipose-derived stem/stromal cells and dermal fibroblasts. J Proteomics. 2021 Feb 10;232:104069. doi: 10.1016/j.jprot.2020.104069. Epub 2020 Dec 10. PMID: 33309826.
28. Zheng Y, Lin C, Hou X, Ma N, Yu W, Xu X, Lou Y, Fei H, Shen Y, Sun X. Enhancing the osteogenic capacity of MG63 cells through N isopropylacrylamide modified polyethylenimine mediated oligodeoxynucleotide MT01 delivery. RSC Adv. 2017;7:27121–27127. doi:10.1039/C6RA27182K
29. Chen G, Deng C, Li YP. TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8(2):272-88. doi: 10.7150/ijbs.2929. Epub 2012 Jan 21. PMID: 22298955; PMCID: PMC3269610.
30. Prasetyaningrum N, Ridwan RD, Saskianti T, Rachmawati D, Virgirinia RP. Prediction of secretome release from hydrogels based on molecular interactions and binding affinity to promoting bone regeneration in periodontitis. Res J Pharm Technol. 2024; 17(11): 5368-74. doi:10.52711/0974-360X.2024.00820.
31. Wicaksono S, Rahmahani J, Ernawati DS, Rantam FA, Budhy TI, Nugraha AP, Nur RM, Indrastie N, Ramadhani NF, Tengku Ahmad Noor TNE. Mesenchymal stem cell secretome as novel regenerative approach in oral ulcerative lesions management: a review. Res J Pharm Technol. 2024; 17(3): 1408-3. doi:10.52711/0974-360X.2024.00223.
32. Timothy CN, Samyuktha PS, Brundha MP. Dental pulp stem cells in regenerative medicine – a literature review. Res J Pharm Technol. 2019; 12(8): 4052-6. doi:10.5958/0974-360X.2019.00698.X
33. Rachmawati D, Saskianti T, Ridwan RD, Prasetyaningrum N, Kanawa M. VEGF as alveolar bone regeneration key protein in SHED secretome, hydroxyapatite and collagen type 1 scaffold: an in-silico study. Res J Pharm Technol. 2024; 17(10): 4998-5004. doi:10.52711/0974-360X.2024.00765.
34. Handajani J, Setia Budi H, R. Amir L and Angky Soekanto S. Effect of Stem Cells from Human Exfoliated Deciduous Teeth Spent Medium (SHED-SM) on the Healing of Traumatic Buccal Mucosal Ulcers. F1000Res. 2025; 14: 510. https://doi.org/10.12688/f1000research.164339.1
35. Prahasanti C, Perdana S. The roles of insulin growth factors-1 IGF-1 in bone graft to increase osteogenesis. Res J Pharm Technol. 2022; 15(4): 1737-42. doi:10.52711/0974-360X.2022.00291.
36. Suciadi SP, Nugraha AP, Ernawati DS, Ayuningtyas NF, Narmada IB, Prahasanti C, Dinaryanti A, Ihsan IS, Hendrinto E, Susilowati H, Rantam FA. The efficacy of human dental pulp stem cells in regenerating submandibular gland defects in diabetic Wistar rats Rattus novergicus. Res J Pharm Technol. 2019; 12(4): 1573-9. doi:10.5958/0974-360X.2019.00261.0
37. Wijaya MG, Prahasanti C, Laksono BD, Agrawanty W, Kusumawardhani B, Anggakusuma MJ. Viability test of hydroxyapatite tooth graft on osteoblast cell culture. Res J Pharm Technol. 2024; 17(2): 855-9. doi:10.52711/0974-360X.2024.00132.
38. Bargowo L, Prahasanti C, Purwaningsih Y, Josefina I, Ridwan RD, Kusumawardani B, Aljunaid MA. Expression of OPG and RANKL in osteoblast cells exposed by polymethylmethacrylate PMMA and hydroxyapatite HAp combination. Res J Pharm Technol. 2025; 18(5): 2055-2.
39. Nugraha AP, Ramadhani NF, Saputra D, Mappananrang RA, Purnamasari AE, Anwar AA, Ridwan RD, Kharisma VD, Putera Nugraha A, Tengku Ahmad Noor TNE, Nawira, Widjiastuti I, Yuanita T. An insight of proanthocyanidin and polyamidoamine-calcium phosphate nanoparticles as biomaterial candidate for dentin regeneration in dental pulp capping: a narrative review. Res J Pharm Technol. 2022; 15(7): 2888-94. doi:10.52711/0974-360X.2022.00482.
40. Nafees Z, Nair K, Paryani MJ, Shrinivas U, Samuel VP, Kumar N. Mesenchymal stem cell therapy–a promising treatment for wound healing in diabetic patients. Res J Pharm Technol. 2024; 17(12): 6043-9. doi:10.52711/0974-360X.2024.00917.